Dec 20, 2022 12:37pm EST IMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Dec 16, 2022 8:00am EST IMV Announces US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Dec 15, 2022 7:05am EST IMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCL
Nov 08, 2022 7:05am EST IMV Inc. to Announce Third Quarter 2022 Results and Host a Conference Call and Webcast on November 11, 2022